Cobb & Associates
Records under this name other than the patents Cobb & Associates holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 1 patents it holds.
Showing 1 to 5 of 5 · Back to Cobb & Associates
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,731,976 | Treatment of irritable bowel syndrome using probiotic composition Term ended Ended no later than Aug 27, 2024 · From the USPTO record | Term ended | Ended no later than Aug 27, 2024 | From the USPTO record |
| US 7,749,509 | Treatment of autism using probiotic composition Term ended Ended no later than Aug 27, 2024 · From the USPTO record | Term ended | Ended no later than Aug 27, 2024 | From the USPTO record |
| US 8,771,673 | Probiotic composition useful for dietary augmentation and/or combating disease states and adverse physiological conditions Lapsed on the fee record Ended Jul 8, 2022 · From the USPTO record | Lapsed on the fee record | Ended Jul 8, 2022 | From the USPTO record |
| US 8,246,946 | Treatment of bipolar disorder utilizing anti-fungal compositions Lapsed on the fee record Ended Aug 21, 2020 · From the USPTO record | Lapsed on the fee record | Ended Aug 21, 2020 | From the USPTO record |
| US 8,192,733 | Probiotic composition useful for dietary augmentation and/or combating disease states and adverse physiological conditions Lapsed on the fee record Ended Jun 5, 2020 · From the USPTO record | Lapsed on the fee record | Ended Jun 5, 2020 | From the USPTO record |